Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... حسب Luke R. Cavanah (19022435)

Z-stack showing <i>N</i>. <i>bombycis</i> adhering to the surface of the ovariole at the vitellogenesis stage on the fifth day of pupation. حسب Chunxia Wang (766713)

الموضوعات:

Z-stack showing <i>N</i>. <i>bombycis</i> infection in follicular cells at the vitellogenesis stage on the fifth day of pupation. حسب Chunxia Wang (766713)

الموضوعات:

Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx حسب Dewan Zhao (21547445)

"…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …"

Z-stack showing <i>N</i>. <i>bombycis</i> infection in the nurse cells and oocytes at the vitellogenesis stage on the fifth day of pupation. حسب Chunxia Wang (766713)

الموضوعات:

Z-stack showing <i>N</i>. <i>bombycis</i> adhering to the surface of the ovariole aat the previtellogenesis stage on the fifth day of pupation. حسب Chunxia Wang (766713)

الموضوعات:

Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX حسب Cong Xu (203537)

"…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …"

Results of SD-TOPSIS application ‐ combinations B1-B5. حسب Roman Vavrek (13200141)

<b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b> حسب Samuel Briggs-Price (17735046)

Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. حسب Garett Dunsmore (11021169)

Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation. حسب Cynthia Alsayyah (18452506)

الموضوعات:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

The rate the bias decreases with sample duration is higher for cells with higher activity levels. حسب Liron Sheintuch (12078310)

Oral infection with YFV-Asibi cap0 leads to lower viral loads in the midguts largely diminishing dissemination to secondary tissues. حسب Anja vom Hemdt (19787189)

الموضوعات:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for BP() and NB() under equal sample sizes (). حسب Mahmut Sami Erdoğan (22097195)

الموضوعات:

Mutation frequency in EOC populations. حسب Mirielle C. Ma (18990490)